Abstract
To clarify the characteristics of hepatocellular carcinoma (HCC) with bile duct invasion, we retrospectively analyzed clinical features and surgical outcome of HCC with bile duct invasion (b+ group, n = 15) compared to those without bile duct invasion (b− group, n = 256). In the b+ group, four patients (27%) showed obstructive jaundice, and a diagnosis of bile duct invasion was obtained preoperatively in seven patients (47%). The levels of serum bilirubin and carbohydrate antigen 19–9 were significantly higher in the b+ group. Macroscopically, confluent multinodular type and infiltrative type were predominant in the b+ group (P = 0.002). Microscopically, capsule infiltration (P = 0.040) and intrahepatic metastasis (P = 0.013) were predominant in the b+ group. Portal vein invasion was associated significantly with the b+ group (P = 0.004); however, the frequency of hepatic vein invasion was similar (P = 0.096). The median survival after resection was significantly shorter in the b+ group than in the b− group (11.4 vs. 56.1 months, P = 0.002), and eight of 11 intrahepatic recurrences in the b+ group occurred within 3 months after surgery. HCC with bile duct invasion has an infiltrative nature and a high risk of intrahepatic recurrence, resulting in poor prognosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kondo K, Chijiiwa K, Makino I, Kai M, Maehara N, Ohuchida J, Naganuma S. Risk factors for early death after liver resection in patients with solitary hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2005;12:399–404. doi:10.1007/s00534-005-1009-9.
Lin TY, Chen KM, Chen YR, Lin WS, Wang TH, Sung JL. Icteric type hepatoma. Med Chir Dig 1975;4:267–270.
Tsuzuki T, Ogata Y, Iida S, Kasajima M, Takahashi S. Hepatoma with obstructive jaundice due to the migration of a tumor mass in the biliary tract: report of a successful resection. Surgery 1979;85:593–598.
Satoh S, Ikai I, Honda G, Okabe H, Takeyama O, Yamamoto Y, Yamamoto N, Iimuro Y, Shimahara Y, Yamaoka Y. Clinicopathologic evaluation of hepatocellular carcinoma with bile duct thrombi. Surgery 2000;128:779–783. doi:10.1067/msy.2000.108659.
Yeh CN, Jan YY, Lee WC, Chen MF. Hepatic resection for hepatocellular carcinoma with obstructive jaundice due to biliary tumor thrombi. World J Surg 2004;28:471–475. doi:10.1007/s00268-004-7185-y.
Lau W, Leung K, Leung TW, Liew CT, Chan MS, Yu SC, Li AK. A logical approach to hepatocellular carcinoma presenting with jaundice. Ann Surg 1997;225:281–285. doi:10.1097/00000658-199703000-00007.
Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, Harihara Y, Takayama T. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997;26:1176–1181.
Liver Cancer Study Group of Japan. General Rules for the Clinical and Pathological Study of Primary Liver Cancer. 2nd ed. Tokyo: Kaneharap 2003.
Kojiro M, Kawabata K, Kawano Y, Shirai F, Takemoto N, Nakashima T. Hepatocellular carcinoma presenting as intrabile duct tumor growth: a clinicopathologic study of 24 cases. Cancer 1982;49:2144–2147. doi:10.1002/1097-0142(19820515)49:10<2144::AID-CNCR2820491026>3.0.CO;2-O.
Shiomi M, Kamiya J, Nagino M, Uesaka K, Sano T, Hayakawa N, Kanai M, Yamamoto H, Nimura Y. Hepatocellular carcinoma with biliary tumor thrombi: aggressive operative approach after appropriate preoperative management. Surgery 2001;129:692–698. doi:10.1067/msy.2001.113889.
Qin LX, Ma ZC, Wu ZQ, Fan J, Zhou XD, Sun HC, Ye QH, Wang L, Tang ZY. Diagnosis and surgical treatments of hepatocellular carcinoma with tumor thrombosis in bile duct: experience of 34 patients. World J Gastroenterol 2004;10:1397–1401.
Wind G, Futterman S. Obstructive jaundice secondary to hepatoma. Case report and literature review. Am J Gastroenterol 1977;67:80–83.
Kew MC, Paterson AC. Unusual clinical presentations of hepatocellular carcinoma. Trop Gastroenterol 1985;6:10–22.
Lai ST, Lam KT, Lee KC. Biliary tract invasion and obstruction by hepatocellular carcinoma: report of five cases. Postgrad Med J 1992;68:961–963.
Peng SY, Wang JW, Liu YB, Cai XJ, Deng GL, Xu B, Li HJ. Surgical intervention for obstructive jaundice due to biliary tumor thrombus in hepatocellular carcinoma. World J Surg 2004;28:43–46. doi:10.1007/s00268-003-7079-4.
Lee NW, Wong KP, Siu KF, Wong J. Cholangiography in hepatocellular carcinoma with obstructive jaundice. Clin Radiol 1984;35:119–123. doi:10.1016/S0009-9260(84)80008-2.
Lau WY, Leung KL, Leung TW, Ho S, Chan M, Liew CK, Leung N, Johnson P, Li AK. Obstructive jaundice secondary to hepatocellular carcinoma. Surg Oncol 1995;4:303–308.
AJCC. AJCC cancer staging manual. 6th ed. New York: Springer, 2002.
Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y, Makuuchi M. Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg 2007;245:909–992. doi:10.1097/01.sla.0000254368.65878.da.
Fukuda S, Okuda K, Imamura M, Imamura I, Eriguchi N, Aoyagi S. Surgical resection combined with chemotherapy for advanced hepatocellular carcinoma with tumor thrombus: report of 19 cases. Surgery 2002;131:300–310. doi:10.1067/msy.2002.120668.
Schwartz JD, Schwartz M, Mandeli J, Sung M. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol 2002;3:593–603. doi:10.1016/S1470–2045(02)00873–2.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ikenaga, N., Chijiiwa, K., Otani, K. et al. Clinicopathologic Characteristics of Hepatocellular Carcinoma with Bile Duct Invasion. J Gastrointest Surg 13, 492–497 (2009). https://doi.org/10.1007/s11605-008-0751-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-008-0751-0